Asis Bala

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 9

Top Venues

Inflammopharmacology

Medical oncology (Northwood, London, England)

The Journal of pharmacy and pharmacology

Endocrine

National Institute of Pharmaceutical Education and Research Hajipur

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Institute of Pharmaceutical Education and Research Hajipur Sep 07 2018 - Nov 22 2019

India

Faculty :: Pharmacology and Toxicology

University of the Free State Mar 30 2017 - Aug 29 2018

South Africa

Fellow faculty (Post Doctoral Research) :: Pharmacology

Guru Nanak Institute of Pharmaceutical Science and Technology Jul 01 2013 - Mar 23 2017

India

ASSISTANT PROFESSOR :: Pharmacology

Publications

Srijon Gayen, Sandipan Jana, Barun Das Gupta, Avijit Ghosh, Amit Kar, Asis Bala, Pulok Kumar Mukherjee, Pallab Kanti Haldar
Exploration of anti-diabetic activity and metabolite profiling of Bruguiera cylindrica (l.) Bl.-in vivo anti-diabetic activity, exploration of molecular mechanism, and network pharmacological analysis. The Journal of pharmacy and pharmacology 76 (7) (2024)
Pratiksha Somnath Kumkar, Ratul Chakraborty, Abhishek Motilal Upadhyay, Jitu Mani Das, Asis Bala
Preliminary study on cytotoxicity of selegiline on different cancer cell lines: exploration of the induction of ROS-independent apoptosis in breast cancer cells. Medical oncology (Northwood, London, England) 41 (8) (2024)
Srijon Gayen, Sandipan Jana, Barun Das Gupta, Avijit Ghosh, Amit Kar, Asis Bala, Pulok Kumar Mukherjee, Pallab Kanti Haldar
Exploration of anti-diabetic activity and metabolite profiling of Bruguiera cylindrica (l.) Bl.-in vivo anti-diabetic activity, exploration of molecular mechanism, and network pharmacological analysis. The Journal of pharmacy and pharmacology (2024)
Pratiksha Somnath Kumkar, Ratul Chakraborty, Abhishek Motilal Upadhyay, Jitu Mani Das, Asis Bala
Preliminary study on cytotoxicity of selegiline on different cancer cell lines: exploration of the induction of ROS-independent apoptosis in breast cancer cells. Medical oncology (Northwood, London, England) 41 (8) (2024)
Asis Bala
Importance of protein kinase C (PKC) in phosphorylation of AMP-activated protein kinase (AMPK) in endocrine control. Endocrine (2023)
Asis Bala
A need for clinical trial: re-purposing the Monoamine Oxidase Inhibitors (MAO-I) for rheumatoid arthritis (RA). Inflammopharmacology (2023)
Debjeet Sur, Chaitali Mondal, Ashok Kumar Balaraman, Pallab Kanti Haldar, Himangshu Sekhar Maji, Asis Bala
Attenuation of COX-2 enzyme by modulating H 2 O 2 -mediated NF-κB signaling pathway by monoamine oxidase inhibitor (MAOI): a further study on the reprofiling of MAOI in acute inflammation. Inflammopharmacology (2023)
Motlalepula Gilbert Matsabisa, Asis Bala, Satyajit Tripathy, Michelle Mogomane Digashu, Fanie Rautenbach, Barsha Dassarma, Joseph Omorogiuwa Erhabor, Fernao Castro Braga, Pulok Kumar Mukherjee, Minke Tang, Youngmin Kang
Study on South African Indigenous Teas-Antioxidant Potential, Nutritional Content, and Hypoxia-Induced Cyclooxygenase Inhibition on U87 MG Cell Line. Molecules (Basel, Switzerland) 27 (11) (2022)
Asis Bala, Chaitali Mondal, Pallab Kanti Haldar, Bidita Khandelwal
Oxidative stress in inflammatory cells of patient with rheumatoid arthritis: clinical efficacy of dietary antioxidants. Inflammopharmacology 25 (6) (2017)

Asis Bala.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Asis Bala